Brensocatib in non-cystic fibrosis bronchiectasis: targeting neutrophil-driven inflammation through DPP-1 inhibition.

Imran SB, Haider E, Faraz B, Kumari P

Open source

DOI
10.1097/ms9.0000000000005111
Published
2026 Jul
Container
Annals of medicine and surgery (2012)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/ms9.0000000000005111,
  title = {Brensocatib in non-cystic fibrosis bronchiectasis: targeting neutrophil-driven inflammation through DPP-1 inhibition.},
  author = {Imran SB and Haider E and Faraz B and Kumari P},
  year = {2026},
  journal = {Annals of medicine and surgery (2012)},
  doi = {10.1097/ms9.0000000000005111},
  url = {https://doi.org/10.1097/ms9.0000000000005111}
}

RIS

TY  - JOUR
TI  - Brensocatib in non-cystic fibrosis bronchiectasis: targeting neutrophil-driven inflammation through DPP-1 inhibition.
AU  - Imran SB
AU  - Haider E
AU  - Faraz B
AU  - Kumari P
PY  - 2026
JO  - Annals of medicine and surgery (2012)
DO  - 10.1097/ms9.0000000000005111
UR  - https://doi.org/10.1097/ms9.0000000000005111
ER  - 

APA

SB, I., E, H., B, F., & P, K. (2026). Brensocatib in non-cystic fibrosis bronchiectasis: targeting neutrophil-driven inflammation through DPP-1 inhibition.. Annals of medicine and surgery (2012). https://doi.org/10.1097/ms9.0000000000005111

Source records